Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Compensated Chronic Hepatitis B”

25 trials

Showing 20 of 25 results

Post-approval studies (Phase 4)WithdrawnNCT00862706
What this trial is testing

Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks

Who this might be right for
Compensated Chronic Hepatitis B
Novartis Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT01088009
What this trial is testing

Efficacy Optimizing Research of Lamivudine Therapy

Who this might be right for
Compensated Chronic Hepatitis B
Nanfang Hospital, Southern Medical University 366
Post-approval studies (Phase 4)WithdrawnNCT00606099
What this trial is testing

Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Novartis
Large-scale testing (Phase 3)Study completedNCT00115245
What this trial is testing

Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Novartis
Post-approval studies (Phase 4)Study completedNCT00646503
What this trial is testing

Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Novartis 150
Post-approval studies (Phase 4)Study completedNCT00641082
What this trial is testing

Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function

Who this might be right for
HBeAg(-) Chronic Hepatitis B With Compensated Liver Function
Bukwang Pharmaceutical 43
Not applicableUnknownNCT04160897
What this trial is testing

Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis

Who this might be right for
Hepatitis B, ChronicHepatocellular CarcinomaCompensated Cirrhosis
Qing XIe 4,000
Testing effectiveness (Phase 2)Study completedNCT00804622
What this trial is testing

Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)

Who this might be right for
Chronic Hepatitis B
The University of Hong Kong 15
Post-approval studies (Phase 4)Study completedNCT00877149
What this trial is testing

Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B

Who this might be right for
Compensated Chronic Hepatitis B
Novartis Pharmaceuticals 80
Testing effectiveness (Phase 2)Study completedNCT00230503
What this trial is testing

Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Bausch Health Americas, Inc. 220
Large-scale testing (Phase 3)Study completedNCT00131742
What this trial is testing

Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Novartis
Post-approval studies (Phase 4)UnknownNCT01529255
What this trial is testing

EFFORT Extension Study

Who this might be right for
Hepatitis B, Chronic
Nanfang Hospital, Southern Medical University 576
Large-scale testing (Phase 3)Study completedNCT00057265
What this trial is testing

A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Novartis
Not applicableUnknownNCT04646928
What this trial is testing

Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
CHA University 245
Large-scale testing (Phase 3)Study completedNCT00316719
What this trial is testing

Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
GlaxoSmithKline 105
Large-scale testing (Phase 3)Study completedNCT00412529
What this trial is testing

Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

Who this might be right for
Hepatitis BChronic Hepatitis B
Novartis Pharmaceuticals 44
Large-scale testing (Phase 3)Ended earlyNCT02058108
What this trial is testing

Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B
Novartis Pharmaceuticals 53
Post-approval studies (Phase 4)UnknownNCT04997564
What this trial is testing

The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
Peking University First Hospital 120
Post-approval studies (Phase 4)Study completedNCT00441974
What this trial is testing

Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients

Who this might be right for
Chronic Hepatitis B
GlaxoSmithKline 1,470
Post-approval studies (Phase 4)Study completedNCT00537537
What this trial is testing

To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B, Chronic
Novartis Pharmaceuticals 100
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation